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Assisted Reproductive Technology (ART) methods are employed to help infertile couples conceive.  One such ART procedure is 
in vitro fertilization (IVF) and embryo culture (EC).  During IVF-EC, supernumerary embryos are often produced and 
cryopreserved for future use.  Embryos frozen and thawed have reduced rates of blastocyst development.  Thawing temperature is 
one of the factors thought to affect embryo development after cryopreservation.  The objective of this study was to determine if 
varying thaw temperatures affect embryo development.  Using a randomized, controlled study, approximately 230 two-cell 
murine embryos were exposed to cryoprotectants and cryopreserved in lots of 15 embryos per straw.  A total of 16 straws were 
cryopreserved.  Cryopreserved embryos were thawed in water baths set at either 30°C (n = eight straws) or 37°C (n = eight 
straws).  Once the straws were thawed and the cryoprotectant removed, the embryos were incubated for 72 hours and assessed for 
blastocyst development.  Proportions between blastocyst developments were analyzed using the Chi square test.  Blastocyst 
development for straws thawed at 30°C was 52.1% (63/121) compared to 45.5% (50/110) for straws thawed at 37°C. These 
values were not significantly different (P = 0.4).  In conclusion, the range of thaw temperature used for this study had no effect 
on post-thaw embryo development.  Future studies should assess other aspects of the thawing procedure, including length of time 
straws remain in the water bath, as well as the effect of pre-thawing straws at room temperature before placing them in the water 
bath.
Introduction 
For three decades, Assisted Reproductive 
Technology (ART) has been helping infertile couples 
conceive.  Since the birth of the first “test-tube baby” in 
1978, reproductive technology has made many advances in 
its ability to overcome infertility (Sher et al., 2005).  
Couples are classified “infertile” if they have not used 
contraception for a year or more and have not conceived.  
In 2004, nearly 50,000 infants were born in the United 
States to “infertile” couples because of ART (Centers for 
Disease Control and Prevention, 2006). 
An in vitro fertilization (IVF) and embryo culture 
(EC) cycle begins when a woman starts taking fertility 
drugs or has her ovaries monitored for follicular 
development (Wright et al., 2004; Centers for Disease 
Control and Prevention, 2006).  The next step is egg-
retrieval, after which the eggs (oocytes) are combined with 
sperm in the laboratory.  The subsequent embryos are 
evaluated morphologically and two to three of the “best” 
embryos are transferred to the patient.  If the transfer is 
successful and implantation occurs, the cycle is deemed a 
clinical pregnancy.  The last step, and ultimate goal, is a 
live-birth delivery, defined as a birth resulting in one or 
more live born neonates (American Society for 
Reproductive Medicine, 2004).  The Center for Disease 
Control and Prevention reported that of the 127,977 IVF-
EC cycles initiated in 2004, 36,760 (28.7%) resulted in 
live-birth deliveries.   
In many cases, infertile women have to undergo 
multiple cycles before pregnancy is established, and even 
more cycles before a live-birth is obtained.  Often times, 
with more cycles initiated comes an increase in number of 
embryos placed back into the uterus.  This increased 
number of embryos transferred often translates into a 
multiple pregnancy.  Unfortunately, multiple pregnancy 
often leads to serious consequences, especially if the 
pregnancy results in triplet births or greater.  Therefore, 
multiple-infant pregnancies should be considered a 
complication of ART, as they are associated with a number 
of problems including higher rates of caesarean section, 
prematurity, low birth weight, and infant disability or 
death.  Nearly one-third of pregnancies resulting from ART 
conclude in multiple-infant live births.   
Distributing the embryos obtained during the 
course of one IVF-EC cycle over a number of cycles is a 
beneficial alternative to undergoing fresh retrievals each 
time (Edgar et al., 2000).  Cryopreserving the embryos 
from the first cycle and using them for later cycles fully 
uses the potential of the first oocyte retrieval, while 
allowing all the embryos resulting from that cycle to be 
used rather than discarded (Jones et al., 1997; Schnorr et 
al., 2000; Edgar et al., 2005).  Cryopreserving also provides 
a useful tool for avoiding multiple-infant pregnancies.  
Instead of transferring numerous embryos in the first 
transfer, some may be stored for another transfer, thus 
reducing the risk of multiple infants (Oehninger et al., 
2000; Cohen et al., 2001) and increasing the probability of 
obtaining a pregnancy with one ART cycle (Jones et al., 
1997).   
 Another complication with the IVF-EC cycle is 
ovarian hyperstimulation syndrome (OHSS), and occurs in 
an estimated 1% to 10% of ART cases when the ovaries are 
stimulated for ovulation induction (Fasouliotis and 
Schenker, 2005).  In extreme cases, OHSS can cause severe 
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morbidity and even death.  If the woman fails to conceive, 
the symptoms disappear rapidly; however, if a pregnancy is 
obtained, the symptoms may become progressively worse 
(Sher et al., 2005).  According to Chung et al. (2006) and 
Edgar et al. (2005), OHSS is a greater risk in multiple-
infant pregnancies and because of this, it is recommended 
that patients with severe OHSS undergo oocyte collection, 
cryopreserve of their embryos, and end the cycle, 
postponing embryo transfer until later.   
 These complications associated with the ART 
process (the need for numerous cycles to obtain a 
pregnancy, multiple-infant pregnancies, and the risks of 
OHSS) have been decreased by the growing use of 
cryopreservation in ART laboratories (Edgar et al., 2000; 
Oehninger et al., 2000; Schnorr et al., 2000; Edgar et al., 
2005).   
Cryopreservation is the preservation of cells, 
tissues, organs, or embryos by freezing.  Since the early 
1980’s, ART has utilized this technology as a means to 
store embryos for future use (Trounson and Mohr, 1983).  
The implementation of cryopreservation has given ART 
clinics the freedom to use fewer embryos for transfer, as 
they are able to store the supernumerary embryos and use 
them later if pregnancy is not established (Edgar et al., 
2005).   Freezing provides an alternative for patients who 
may not wish to discard unused embryos, but who are also 
wary of a multiple-infant pregnancy and so do not wish to 
transfer all the embryos at once.   
 Even though cryopreservation is advantageous 
for patients, it has its own drawbacks.  The 2005 National 
Summary of ART clinics in the United States reported that 
the percentage of transfers resulting in live births from 
fresh embryos in women under 35 years of age was about 
43%, while only 32% of thawed embryos resulted in live 
births (Society for Assisted Reproductive Technology, 
2006).  However, some believe that the strict criteria used 
to choose fresh embryos for transfer gives an advantage to 
those embryos and, consequently, a disadvantage to those 
embryos left for cryopreservation (Edgar et al., 2000).   
Edgar et al. (2000) found that nearly 45% of 
thawed embryos suffered some amount of blastomere (cell) 
loss, causing an approximate 30% reduction in 
implantation.  They also suggested from these data that 
80% of the resulting implantations arise from thawed 
embryos, which suffered no blastomere loss.  Therefore, if 
methods can be altered in such a way as to protect the 
blastomeres from damage during cryopreservation/ 
thawing, the patient should have an improved chance for 
implantation with the thawed embryos. 
The purpose of this study was to determine if 
varying the temperatures at which cryopreserved embryos 
are thawed affects the rate of post-thaw blastocyst 
development.    
 
Materials and Methods 
Animals 
 The complete cryopreservation procedure for 
mouse embryos has been described earlier (Boone et al, 
2004). Specific pathogen-free mice (B6C3F1) were 
obtained from Jackson Labs.  Female mice were 
superovulated with intraperitoneal injection of 5.0 
International Units (IU) of pregnant mare’s serum 
gonadotropin (PMSG; Calbiochem, San Diego, CA).  Each 
female was injected intraperitoneally with 5.0 IU human 
chorionic gonadotropin (hCG; Sigma Aldrich, St. Louis, 
MO) 48 hours after PMSG injection and immediately 
placed with a male.  Females were sacrificed approximately 
43 hours after hCG injection.  Embryos were collected via 
oviductal lavage using approximately 0.1 mL of 
Dulbecco’s phosphate-buffered saline.  Only 
morphologically normal two-cell embryos were used in the 
study.  All of these procedures complied with an approved 
Animal Research Committee protocol.   
 
Cryopreservation 
Embryos were cryopreserved in 1.5M 
propanediol and 0.1M Sucrose (SAGE In-Vitro 
Fertilization, Inc., Trumbull, CT), and subsequently frozen 
at the two-cell stage of development using the Sage 
Embryo Freeze protocol.  Embryos were moved through 
three increasing levels of cryoprotectant to help remove 
water from the cells.  Fifteen embryos were loaded into a 
plastic straw and heat sealed.  A total of 16 straws were 
used in this experiment.  Next, the straws were placed in a 
programmable freezer (Planer Freezer, Planer Co., UK) and 
cooled using the following settings:  Ramp 1) 23°C to -6°C 
at minus 2°C per minute; Ramp 2) held at -6°C for 15 
minutes for seeding (seeded 5 minutes into the ramp with 
10 minutes post-seeding soak); Ramp 3) -6°C to -35°C at 
minus 0.3°C per minute; Ramp 4) held for 5 minutes; 
Ramp 5) -35°C to -180°C at minus 50°C per minute; and 
Ramp 6) held at -180°C for 5 minutes.  The straws then 
were removed from the freezing chamber and plunged into 
liquid nitrogen for storage. 
 
Thaw Procedure 
Cryopreserved straws were thawed individually.  
Each was removed from the liquid nitrogen tank and 
allowed to thaw for 30 seconds at room temperature.  The 
straw then was placed in a water bath for 30 seconds.  Eight 
straws were thawed in water baths set at 30°C, and eight 
straws were thawed in water baths set at 37°C.   
Cryoprotectant was removed by exposing the embryos to 
decreasing concentrations of cryoprotectant (Quinn’s 
Advantage Thaw Kit, SAGE In-Vitro Fertilization, Inc., 
Trumbull, CT).  Upon removal of the cryoprotectants, the 
embryos were incubated for 72 hours and assessed for 
blastocyst development based on morphology. 
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Statistics 
  Proportions between blastocyst development for 
the embryos in the two different thaw temperatures were 
analyzed using the Chi square test.   
Results 
Blastocyst development for straws thawed at 
30°C was 52.1% (63/121), compared with 45.5% (50/110) 
for straws thawed at 37°C. These two developmental rates 
were not statistically different (P = 0.4).  Data are depicted 
in Table 1.   
Figure 1 shows four embryos thawed in the 
course of this study.  Embryo A is a blastocyst, 
characterized by the intact zona pellucida.  Embryo B is an 
early blastocyst that has an extruded degenerated 
blastomere.  Embryo C is a morula containing degenerated 
blastomeres.  Embryo D is a degenerated four-cell embryo.  
This figure represents the type of embryos observed in this 
project.  For our data, two of these embryos were classified 
as blastocysts and two as non-blastocysts. 
Thaw 
Temperature 
(°C) 
Non-
blastocyst 
(%) 
 
Blastocyst 
(%) 
P value 
30 
47.9 
(58/121) 
52.1 
(63/121) 
0.4 
37 
54.5 
(60/110) 
45.5 
(50/110) 
Table 1. Percent of post-thaw mouse blastocyst development after 
thawing in different temperatures.  
Discussion 
Cryopreservation has been a useful tool for 
infertile couples undergoing IVF-EC.  However, thawed 
embryos have reduced rates of blastocyst development 
which adversely affects birth rates.  The objective of this 
study was to assess the effect of different thaw 
temperatures on post-thaw blastocyst development.   
Thaw procedures reported in other studies differ 
considerably.  Valojerdi et al. (2002) reported thawing two-
cell mouse embryos for 10 seconds at room temperature 
before shaking them in a 20°C water bath for 20 seconds 
and subsequently passing them through a series of dilution 
and rehydration steps.  Another study reported thawing the  
Figure 1. Development of four murine embryos 72 hours post-
thaw. 
vials in which the embryos were stored in a water bath at 
31°C for 3 minutes before moving the embryos through a 
series of dilutions to remove the cryoprotectants (Burns et 
al., 1999).  These two examples demonstrate how diverse 
the procedures are for thawing cryopreserved embryos, 
with a time difference of over two-and-one-half minutes 
and a temperature difference of 11°C. 
For our study, murine embryos were 
cryopreserved and sequentially thawed in water baths at 
30°C or 37°C for 30 seconds.  Our results determined no 
significant difference in post-thaw murine blastocyst 
development between embryos thawed at 30°C and those 
thawed at 37°C.  This may provide evidence to suggest that 
slightly varying thaw temperatures are inconsequential to 
the development of post-thaw blastocysts.  However, many 
other aspects of the cryopreservation process should be 
assessed to determine their roles in affecting thawed-
embryo development.  For example, just as the time and 
temperature of reported thaw procedures varied, so do the 
dilution and rehydration steps.  Perhaps if more accurate 
and precise methods can be developed for thawing 
cryopreserved embryos, subsequent thawed-embryo 
development rates, and ultimately birth rates, can be 
improved. 
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